<DOC>
	<DOCNO>NCT00192218</DOCNO>
	<brief_summary>To measure effectiveness influenza vaccination school child compare , target ( i.e. , child offer FluMist ) control ( i.e. , child offer FluMist ) school family .</brief_summary>
	<brief_title>Study Evaluate Effectiveness FluMist Vaccination School-Based Intervention Program</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<criteria>Healthy child enrol target school . Written inform consent obtain child 's parent ( ) agree participate . History severe hypersensitivity ( anaphylactic response ) egg product previous FluMist FluMist license exclusively use healthy individual age 549 year . Therefore child annual receipt inactivate influenza vaccine specific medical condition ( ) recommend eligible . These condition include : Asthma , chronic pulmonary disease , kidney disease , metabolic disease , heart disease , hemoglobinopathy Immunosuppression child Severe immunosuppression household member Pregnancy Past history GuillianBarre Syndrome Aspirin therapy within 1 month prior FluMist anticipate use aspirin contain product one month FluMist administration Administration inactivate vaccine within 2 week live vaccine within 4 week prior receipt FluMist Received antiinfluenza medication past 48 hour Fever past 72 hour Moderate severe nasal congestion ( inability breathe nose ) acute phase URI symptom congestion improve</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>September 2008</verification_date>
</DOC>